IFITM3 and COVID-19: Thus, from our results it can be hypothesized that increased IFITM3 expression in blood cells can contribute to the lymphopenia that is commonly observed in patients with COVID-19, and which was suggested could serve as a predictor for the prognosis of patients [53].